3 results match your criteria: "CHU (University Hospital) of Treichville[Affiliation]"
Molecular confirmation of HIV-1 and HIV-2 coinfections among initially serologically dually-reactive samples from patients living in West Africa.
PLoS One
April 2023
Service de Virologie, Université Paris Cité, INSERM, IAME, UMR 1137, AP-HP, Hôpital Bichat-Claude Bernard, Paris, France.
Article Synopsis
- - This study aimed to confirm co-infections of HIV-1 and HIV-2 in West African patients using specialized tests and molecular methods.
- - Conducted from April 2016 to October 2017 in major clinics in Côte d'Ivoire and Burkina Faso, the survey involved 91 patients who underwent various serological and molecular tests for HIV confirmation.
- - Results showed that out of the 91 participants, 75.4% had both HIV-1 and HIV-2, highlighting the need for improved molecular diagnostics to better identify these co-infections in the region.
Validation of dried blood spots samples for the screening of hepatitis B virus surface by enzyme immunoassay method.
J Immunol Methods
February 2023
Immunology Unit, UFR Pharmaceuticals and Biological Sciences, Félix Houphouët-Boigny University, BPV 34 Abidjan 01, Abidjan, Ivory Coast; Research and Diagnosis Center for AIDS and other infectious diseases (CeDReS), CHU (University Hospital) of Treichville, BP V3 Abidjan 01, Abidjan, Ivory Coast.
Dried Blood Spots (DBS) are blood collection carriers that facilitate the storage and transport of samples. Used for quality control during sero-epidemiological investigations, DBS eluate are not the conventional specimen indicated by manufacturers for enzyme immunoassay method (EIA) for hepatitis B virus surface (HBs antigen). The aim of our study was to evaluate DBS eluates used as a matrix for EIA of HBs antigen in a reference laboratory.
View Article and Find Full Text PDFEvaluation of Four Rapid Tests for Detection of Hepatitis B Surface Antigen in Ivory Coast.
J Immunol Res
May 2021
Félix Houphouët-Boigny University, Abidjan, Côte d'Ivoire.
Background: Hepatitis B virus (HBV) infection is a leading cause of liver disease worldwide. Hepatitis B surface antigen (HBsAg) rapid diagnostic tests (RDTs) could be an ideal tool for a large-scale HBV screening in settings with high endemicity but limited infrastructure. The aim of this study was to evaluate the diagnosis performance of such RDTs for screening HBV infection in Ivory Coast.
View Article and Find Full Text PDF